 | Up a level |
Plöckinger, U; Prasad, V; Ziagaki, A; Tiling, N; Pöllinger, Alexander (2018). 2-deoxy-2-[18]fluoro-D-glucose PET/CT (18FDG PET/CT) may not be a viable biomarker in Pompe disease. Human genomics, 12(1), p. 14. BioMed Central 10.1186/s40246-018-0145-7
Kaemmerer, D; Posorski, N; von Eggeling, F; Ernst, G; Hörsch, D; Baum, R P; Prasad, V; Langer, Rupert; Esposito, I; Klöppel, G; Sehner, S; Knösel, T; Hommann, M (2014). The search for the primary tumor in metastasized gastroenteropancreatic neuroendocrine neoplasm. Clinical & experimental metastasis, 31(7), pp. 817-827. Springer 10.1007/s10585-014-9672-3
